The Center for Blood Cancers will house a new program for multiple myeloma care, as well as expanded services for patients, new and ongoing research initiatives, and expanded educational resources for students and faculty at the NYU School of Medicine. Space for labs and cell processing also will be increased, while infusion and exam rooms will be added to ensure efficient patient flow.
According to the National Foundation for Cancer Research, blood cancers account for nearly 10 percent of all new cancer cases in the United States annually — with the most common being leukemia, lymphoma, and multiple myeloma. Multiple myeloma affects antibody-producing plasma cells, preventing the normal production of cells in bone marrow, and can lead to a compromised immune response, bone destruction, bone marrow failure, and other complications.
"There is a pressing need for more research in the areas of early diagnosis and prevention of blood cancers," said Perlmutter Cancer Center director Benjamin G. Neel. "As a nationally recognized cancer center, we are proud to continue to be on the leading edge of research and clinical care in this area. This gift will help us as attract new talent, leaders, and added expertise to further our mission to prevent and treat these deadly diseases."